GD Stein, Niger

Frank A W Coumans


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 58(Granted Patents)


Location History:

  • GD Stein, NE (US) (2010)
  • GD Stein, NL (2010)
  • GD Stein, NE (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Frank A W Coumans - Revolutionizing Cell Enumeration and Diagnostic Imaging

Introduction:

In today's Innovator Spotlight, we focus on Frank A W Coumans, an esteemed inventor in the field of cell enumeration and diagnostic imaging. With a passion for developing cost-effective and efficient solutions, his innovations have the potential to transform various industries and improve healthcare outcomes. Let's explore his latest patents and the company he works for.

Innovations:

Frank A W Coumans currently holds three patents, showcasing his expertise and contributions in the field. Two notable inventions are "Methods and algorithms for cell enumeration in a low-cost cytometer" and "Diagnostic imaging device for the analysis of circulating rare cells."

1. Methods and algorithms for cell enumeration in a low-cost cytometer:

Cell enumeration through flow cytometry is a crucial process across multiple disciplines. However, the high costs, size, and complexity of existing instruments limit their widespread use. Frank Coumans' novel device, methods, and algorithms address these limitations effectively.

This innovative system employs fluorescent and magnetic labeling techniques to specific target cells in a sample. By using wedge-shaped magnets to selectively move magnetically labeled cells to the observation surface of a cuvet, the device allows for precise cell enumeration. Image analysis, powered by a groundbreaking algorithm, provides an accurate cell count related to the target cell concentration in the original sample. This compact and user-friendly cytometer can be utilized even in remote locations, enabling broader access to critical diagnostic tools.

2. Diagnostic imaging device for the analysis of circulating rare cells:

Frank Coumans' second patent focuses on the development of a diagnostic imaging device specifically designed for analyzing circulating tumor cells from blood samples. The system caters to clinical laboratory settings where space efficiency and minimal operator intervention are essential.

By enriching blood samples, this invention enables the enumeration and identification of target cells, aiding in the screening and detection of early-stage pre-metastatic cancer. It also proves valuable for monitoring disease remission in response to therapy and optimizing treatment regimens for individual patients. With its potential to facilitate personalized medicine, this invention represents a significant step forward in precise cancer diagnosis.

Company and Collaborators:

Frank A W Coumans is affiliated with Veridex, LLC - a renowned company known worldwide for its groundbreaking contributions to the field of diagnostics. Veridex, LLC, with its commitment to advancing medical technologies, provides an ideal environment for Frank Coumans to innovate and bring his creations to life.

Within Veridex, Frank Coumans collaborates with talented peers who share his passion for innovation. Notably, coworkers Frank P Modica and John Verrant contribute to a collaborative work environment, further enhancing the potential for groundbreaking discoveries.

Conclusion:

Frank A W Coumans is a visionary inventor whose groundbreaking patents in cell enumeration and diagnostic imaging hold immense potential for various applications. His dedication to making cutting-edge technologies economically viable and accessible in remote locations represents a significant leap forward in the healthcare industry.

We eagerly anticipate Frank Coumans' future contributions and remain inspired by his commitment to transforming lives through innovation.

If you have any further questions or would like to explore more inventors and their patents, feel free to visit our website idiyas.com, the hub of innovation and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…